专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-2008287407-A1 优先权日:2003-12-10 标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use 发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI 权利人:NITROMED INC 摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.
专利号:US-2008227851-A1 优先权日:2007-03-12 标题 :Laulimalide and laulimalide analogs 发明人:WENDER PAUL A 权利人:WENDER PAUL A 摘要:Novel laulimalide analogs, methods for the treatment of proliferative disease and processes for the synthesis of laulimalide and novel laulimalide analogs are described.
专利号:US-10814013-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
专利号:US-2008107598-A1 优先权日:2006-10-05 标 题:Efficient Synthesis of Chelators for Nuclear Imaging and Radiotherapy: Compositions and Applications
专利号:US-8933207-B2 优先权日:2010-07-28 标 题 :Drug-ligand conjugates, synthesis thereof, and intermediates thereto 发明人:CHEN ZHIYU; LANCASTER THOMAS M; ZION TODD C 权利人:CHEN ZHIYU; LANCASTER THOMAS M; ZION TODD C; SMARTCELLS INC 摘要:The present invention relates to methods for synthesizing compounds of formula I or pharmaceutically acceptable salts thereof: I wherein each of X, Alk 1 , Alk 2 , and W are as defined and described herein.
1: Wise PH, Rihan Z, Dinwiddy G, Whichelow MJ, Butterfield WJ. Clopamide and carbohydrate metabolism. Med J Aust. 1969 Oct 18;2(16):795-8. doi: 10.5694/j.1326-5377.1969.tb107423.x. 7(16):13870-13877. doi: 10.1021/acsomega.2c00256. 3: McNeil JJ, Conway EL, Drummer OH, Howes LG, Christophidis N, Louis WJ. Clopamide: plasma concentrations and diuretic effect in humans. Clin Pharmacol Ther. 1987 Sep;42(3):299-304. doi: 10.1038/clpt.1987.151. 150(11):646, 648, 651-2. 19(3):161-8. doi: 10.1177/000331976801900304. 10(1):34-7. doi: 10.1080/07315724.1991.10718123. 125:236-44. doi: 10.1016/j.jpba.2016.03.051. Epub 2016 Mar 25. 1(8268):355-8. doi: 10.1016/s0140-6736(82)91390-3. 74(3):219-25. doi: 10.1159/000174200. 26(8):337-40. doi: 10.1111/j.1532-5415.1978.tb03680.x. 78(8):679-82. doi: 10.1002/jps.2600780815. 83(4-5):336-42. French. 46(8):654-69. Italian. 66(18):682-4.
合成参考文献
摘要:Vichi FL, da Silva EJ, Cesar EB, Machado RR, Gigante E. [Effect of DCR-515 essental arterial hypertension of moderate severity(preliminary communition)]. Hospital (Rio J). 1969 Jul;76(1):99–106. 摘要:Bernik V. [Modern therapy of the stabilization of essential hypertension by using a new drug combination: Bridina]. Hospital (Rio J). 1969 Aug;76(2):589–99. 摘要:Elizalde JE. [Clinical test using Brinaldix plus Hydergine]. Hospital (Rio J). 1967 Dec;72(6):1941–2. 摘要:Flückiger E, Taeschler M. [Extrarenal effects of a salidiuretic]. Arzneimittelforschung. 1966 Sep;16(9):1183–6. 摘要:Frank H, Dentler H. [Clinical experiences with Brinaldix]. Munch Med Wochenschr. 1966 Nov 04;108(44):2235–40.